Post by crystalriver on Nov 20, 2009 18:47:25 GMT -5
If anyone here can bring forward this Jpeg of the transhumanist please do so--Thank You--CrystalRiver
www.rumormillnews.com/cgi-bin/forum.cgi?read=160864
Who Are The Stake Holders in The Morgellons Information Release?
Posted By: CrystalRiver <Send E-Mail>
Date: Friday, 20-Nov-2009 13:40:21 Dear RM Agents and Readers,
It is obvious that those with this condition should hold the highest stake; at least in my mind. Yet, what of those involved in the many patents that look to be showing up regarding Morgellons? What about the roles of the Universities, the Biolabs, DOD, NASA, DARPA, DOE, DOA, NIH, CDC ect---how many of these can we call stake holders? What about the billions of dollars put into nanotechnology--I think we could have built a couple more colliders on this budget; not promoting them--just attempting to give you the picture of how much has been spent in the area of nanotechnology.
What about the people that have been affected and those that don't even realize what is happening or those that haven't put the pieces together. What about the families that have lost their moms and dads, grandmothers and grandfathers? You have to admit if you want to bring a country down Morgellons is a perfect avenue; a country is only as strong as its smallest unit---the family.
Many Blessings,
CrystalRiver
------------------------------------------------------
From Jan Smith's page with my add on of acronym terms that were used by the CDC.
------------------------------------------------
Current Information
11/05/2009 - Update to CDC Unexplained Dermopathy Investigation Website
"CDC’s CCID Board of Scientific Counselors met in November 2009 and was provided an update on the progress of the panel’s review (Preliminary Report on Progress of External Peer Review of CDC's Unexplained Dermopathy Project to the CCID Board of Scientific Counselors [PDF, 11 KB]). When CDC receives a report from the external review panel, it will be made available on this website."
Preliminary Report on Progress of External Peer Review of
CDC’s Unexplained Dermopathy Project
to the CCID Board of Scientific Counselors
November 4, 2009
In January 2008, CDC launched an epidemiologic investigation of an unexplained skin condition which some refer to as "Morgellons." The primary goals of the investigation are to help us learn more about who may be affected with this condition and the symptoms they experience and to generate hypotheses about factors that may contribute to it. Data collection has been completed and analysis is ongoing. This investigation was conducted out of the National Center for Zoonotic, Vector-borne, and Enteric Diseases’ (NCZVED) Division of Parasitic Diseases (DPD), with input from a cross-agency, multi-disciplinary workgroup. On September 24, 2009, DPD convened an external review panel to examine study activities to date and provide advice on future activities. DPD outlined several questions for the panel to address: 1. Have the project’s goals and priorities been addressed?
2. What are the study’s strengths?
3. What are the study’s limitations?
4. Are there gaps of concern or need for additional study?
5. What findings can be communicated to the public, medical community, and stakeholder community?
(Editors Note: Take a good look at #5 above. Who or what is the "stakeholder community?"
What findings need to be kept secret from the sufferers of this disease? Who has the right to determine how much truth should be withheld from anyone. Is this still The United States of America?)
6. What is the public health impact of this study?
7. What should the priorities be in the future?
The panel has not yet released a report of its findings to CDC. When we receive a report from the panel, we will share it with members of the BSC, along with the program’s response to the panel’s findings and recommendations. DPD and NCZVED leadership will meet with CDC leadership to discuss options for future program activities to address any issues raised by the panel, including considerations for potential organizational home for further research.
------------------------------------------------------
CDC/Primary Containment for Biohazards (BSC's)
SECTION 5 - BSC Use by the Investigator: ... The Class II, Type B1 BSC (classic design) Figure 5B. ... Figure 10. A modified containment cabinet or Class I BSC ...
www.cdc.gov/od/ohs/biosfty/bsc/bsc.htm - Cached
----------------------------------------------
NCZVED Defined:
CDC - National Center for Zoonotic, Vector-Borne, and Enteric ...
Division of the CDC that provides leadership, expertise, and service in laboratory and epidemiological science, ... NCZVED Homepage. Director. Divisions. DFBMD ...
www.cdc.gov/nczved - Cached
-------------------------------------------------
DPD Defined:
Home | CDC DPD
CDC en Español. Search: Parasitic Diseases. Spotlight: Neglected Infections of Poverty ... Content Source: Division of Parasitic Diseases (DPD) ...
www.cdc.gov/ncidod/dpd - Cached
www.rumormillnews.com/cgi-bin/forum.cgi?read=160864
Who Are The Stake Holders in The Morgellons Information Release?
Posted By: CrystalRiver <Send E-Mail>
Date: Friday, 20-Nov-2009 13:40:21 Dear RM Agents and Readers,
It is obvious that those with this condition should hold the highest stake; at least in my mind. Yet, what of those involved in the many patents that look to be showing up regarding Morgellons? What about the roles of the Universities, the Biolabs, DOD, NASA, DARPA, DOE, DOA, NIH, CDC ect---how many of these can we call stake holders? What about the billions of dollars put into nanotechnology--I think we could have built a couple more colliders on this budget; not promoting them--just attempting to give you the picture of how much has been spent in the area of nanotechnology.
What about the people that have been affected and those that don't even realize what is happening or those that haven't put the pieces together. What about the families that have lost their moms and dads, grandmothers and grandfathers? You have to admit if you want to bring a country down Morgellons is a perfect avenue; a country is only as strong as its smallest unit---the family.
Many Blessings,
CrystalRiver
------------------------------------------------------
From Jan Smith's page with my add on of acronym terms that were used by the CDC.
------------------------------------------------
Current Information
11/05/2009 - Update to CDC Unexplained Dermopathy Investigation Website
"CDC’s CCID Board of Scientific Counselors met in November 2009 and was provided an update on the progress of the panel’s review (Preliminary Report on Progress of External Peer Review of CDC's Unexplained Dermopathy Project to the CCID Board of Scientific Counselors [PDF, 11 KB]). When CDC receives a report from the external review panel, it will be made available on this website."
Preliminary Report on Progress of External Peer Review of
CDC’s Unexplained Dermopathy Project
to the CCID Board of Scientific Counselors
November 4, 2009
In January 2008, CDC launched an epidemiologic investigation of an unexplained skin condition which some refer to as "Morgellons." The primary goals of the investigation are to help us learn more about who may be affected with this condition and the symptoms they experience and to generate hypotheses about factors that may contribute to it. Data collection has been completed and analysis is ongoing. This investigation was conducted out of the National Center for Zoonotic, Vector-borne, and Enteric Diseases’ (NCZVED) Division of Parasitic Diseases (DPD), with input from a cross-agency, multi-disciplinary workgroup. On September 24, 2009, DPD convened an external review panel to examine study activities to date and provide advice on future activities. DPD outlined several questions for the panel to address: 1. Have the project’s goals and priorities been addressed?
2. What are the study’s strengths?
3. What are the study’s limitations?
4. Are there gaps of concern or need for additional study?
5. What findings can be communicated to the public, medical community, and stakeholder community?
(Editors Note: Take a good look at #5 above. Who or what is the "stakeholder community?"
What findings need to be kept secret from the sufferers of this disease? Who has the right to determine how much truth should be withheld from anyone. Is this still The United States of America?)
6. What is the public health impact of this study?
7. What should the priorities be in the future?
The panel has not yet released a report of its findings to CDC. When we receive a report from the panel, we will share it with members of the BSC, along with the program’s response to the panel’s findings and recommendations. DPD and NCZVED leadership will meet with CDC leadership to discuss options for future program activities to address any issues raised by the panel, including considerations for potential organizational home for further research.
------------------------------------------------------
CDC/Primary Containment for Biohazards (BSC's)
SECTION 5 - BSC Use by the Investigator: ... The Class II, Type B1 BSC (classic design) Figure 5B. ... Figure 10. A modified containment cabinet or Class I BSC ...
www.cdc.gov/od/ohs/biosfty/bsc/bsc.htm - Cached
----------------------------------------------
NCZVED Defined:
CDC - National Center for Zoonotic, Vector-Borne, and Enteric ...
Division of the CDC that provides leadership, expertise, and service in laboratory and epidemiological science, ... NCZVED Homepage. Director. Divisions. DFBMD ...
www.cdc.gov/nczved - Cached
-------------------------------------------------
DPD Defined:
Home | CDC DPD
CDC en Español. Search: Parasitic Diseases. Spotlight: Neglected Infections of Poverty ... Content Source: Division of Parasitic Diseases (DPD) ...
www.cdc.gov/ncidod/dpd - Cached